Latent autoimmune diabetes of adulthood (LADA): An often misdiagnosed type of diabetes mellitus

Journal of the American Academy of Nurse Practitioners

Volumn 21, Issue 3, 2009, Pages 156-159

  Appel, Susan J ^a   Wadas, Theresa M ^a,b   Rosenthal, Richard S ^a   Ovalle, Fernando ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Autoimmune; Diabetes mellitus; LADA; Type 1.5 diabetes

Indexed keywords

ANTIIDIOTYPIC ANTIBODY;

AGE; ARTICLE; ATTITUDE TO HEALTH; AUTOIMMUNE DISEASE; BLOOD; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOLOGY; METHODOLOGY; NURSE ATTITUDE; NURSE PRACTITIONER; NURSING; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; RISK FACTOR; UNITED STATES;

AGE FACTORS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOIMMUNE DISEASES; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NURSE PRACTITIONERS; NURSE'S ROLE; NURSING ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 62349109551     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2009.00399.x     Document Type: Article

References (15)

1. Anaya, J. M., Castiblanco, J., Tobon, G. J., Garcia, J., Abad, V., Cuervo, H., et al 2006). Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. Journal of Autoimmunology, 26 (3 208 214.
2. Beales, P. E. Pozzilli, P 2002). Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: Implications for human type 1 diabetes. Diabetes-Metabolism Research and Reviews, 18 (2 114 117.
3. Behme, M. T., Dupre, J., Harris, S. B., Hramiak, I. M. Mahon, J. L 2003). Insulin resistance in latent autoimmune diabetes of adulthood. Annals of the New York Academy of Sciences, 1005, 374 377.
4. Bell, D. S. Ovalle, F 2004). The role of C-peptide levels in screening for latent autoimmune diabetes in adults. American Journal of Therapy, 11 (4 308 311.
5. Chiu, H. K., Tsai, E. C., Juneja, R., Stoever, J., Brooks-Worrell, B., Goel, A., et al 2007). Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients. Diabetes Research and Clinical Practice, 77 (2 237 244.
6. Falorni, A. Calcinaro, F 2002). Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults. Annals of the New York Academy of Sciences, 958, 99 106.
7. Fourlanos, S., Dotta, F., Greenbaum, C. J., Palmer, J. P., Rolandsson, O., Colman, P. G., et al 2005). Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia, 48 (11 2206 2212.
8. Fourlanos, S., Perry, C., Stein, M. S., Stankovich, J., Harrison, L. C. Colman, P. G 2006). A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care, 29 (5 970 975.
9. Grasso, Y. Z., Reddy, S. K., Rosenfeld, C. R., Hussein, W. I., Hoogwerf, B. J., Faiman, C., et al 2001). Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: Prevalence and correlation with clinical features. Endocrinology Practice, 7 (5 339 345.
10. Litonjua, P., Pinero-Pilona, A., Aviles-Santa, L. Raskin, P 2004). Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes. Endocrinology Practice, 10 (2 101 106.
11. Maruyama, T., Shimada, A., Kanatsuka, A., Kasuga, A., Takei, I., Yokoyama, J., et al 2003). Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): Preliminary report. Annals of the New York Academy of Sciences, 1005, 362 369.
12. Notkins, A. L 2004). Type 1 diabetes as a model for autoantibodies as predictors of autoimmune diseases. Autoimmunology Review, 3 (Suppl. 1 S7 S9.
13. Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., et al 2004). C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: Report of an ADA workshop, 21-22 October 2001. Diabetes, 53 (1 250 264.
14. Schranz, D. B., Bekris, L., Landin-Olsson, M., Torn, C., Nilang, A., Toll, A., et al 2000). Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS). Hormone and Metabolism Research, 32 (4 133 138.
15. Torn, C., Landin-Olsson, M., Ostman, J., Schersten, B., Arnqvist, H., Blohme, G., et al 2000). Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds. Diabetes-Metabolism Research and Reviews, 16 (6 442 447.